RARA CRAFT DATABASE for FDA Medical Devices
510(k)K172373

FDA DEVICE FACTS

Compound W Nitro-Freeze

Medtech Products, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATENovember 2, 2017PRODUCT CODEGEH

Indications for use

The Compound W® Nitro-Freeze is an over-the-count er (OTC) device that is intended to be used by lay people to treat common warts and plantar warts. The Compound W® Nitro-Freeze bears the following indications for use statement: Compound W® Nitro-Freeze is intended for over-the-counter treatment of common warts and plantar warts in adults and children four years of age or older. Compound W® Nitro-Freeze has the same intended use as the predicate devices and very minor differences between Compound W® Nitro-Freeze and the predicates with respect to the wording of the indications for use statements do not alter the devices’ intended therapeutic effect.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 28, 2026